R. R. Fagamov
Research Subjects
R. R. Fagamov has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra D. Kufterina
Central State Medical Academy of Department of Presidential Affairs
1 shared publication - Dmitry Felixovich Beloyartsev
Vascular Surgery Department, A. V. Vishnevsky National Medical Research Center of Surgery, 27 Bolshaya Serpukhovskaya Street, 117997 Moscow, Russia
1 shared publication - Elmira F. Galimova
Bashkir State Medical University
1 shared publication - I. V. Sakhautdinova
Bashkir State Medical University, Ufa, Russian Federation
1 shared publication - Konstantin S. Mochalov
Bashkir State Medical University
1 shared publication - Saida Sh. Galimova
Bashkir State Medical University
1 shared publication
Latest Publications
- Open Access
- 11 January 2024
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 43 (6) , 170-176
Antiradical and immunomodulatory effects of gynecological capsules developed for complex treatment of diseases of the female reproductive system
Aim of the study was to evaluate the antiradical and immunomodulatory effects of gynecological capsules (ovules) developed for the complex treatment of diseases of the female reproductive system.Material and methods. Antiradical activity of gynecological capsules (ovuli) was evaluated in cell-free model systems by the ability to suppress the hyperproduction of free radical agents caused by the introduction of iron sulfate. Immunomodulatory activity was determined in the whole blood by their effect on the ability of phagocytic cells to generate reactive oxygen species.Results. In cell-free model systems, the studied drug composition suppressed the activation of free radical oxidative processes induced by the iron sulfate, while at the same time enhancing the production of reactive oxygen species by leukocytes.Conclusions. The results obtained may indicate that the developed gynecological capsules have antiradical and immunomodulatory activity, which allows us to consider them as a promising tool for the treatment of diseases of the female reproductive system.
- 11 January 2024
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 43 (6) , 170-176
Open AccessAntiradical and immunomodulatory effects of gynecological capsules developed for complex treatment of diseases of the female reproductive system
Aim of the study was to evaluate the antiradical and immunomodulatory effects of gynecological capsules (ovules) developed for the complex treatment of diseases of the female reproductive system.Material and methods. Antiradical activity of gynecological capsules (ovuli) was evaluated in cell-free model systems by the ability to suppress the hyperproduction of free radical agents caused by the introduction of iron sulfate. Immunomodulatory activity was determined in the whole blood by their effect on the ability of phagocytic cells to generate reactive oxygen species.Results. In cell-free model systems, the studied drug composition suppressed the activation of free radical oxidative processes induced by the iron sulfate, while at the same time enhancing the production of reactive oxygen species by leukocytes.Conclusions. The results obtained may indicate that the developed gynecological capsules have antiradical and immunomodulatory activity, which allows us to consider them as a promising tool for the treatment of diseases of the female reproductive system.
- 23 April 2023
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 12,p. 95-102
Treatment of atherosclerotic lesion of the first segment of subclavian artery
Severe subclavian artery lesion is an important medical and social problem worsening the quality of life and leading to dire consequences. Vertebrobasilar insufficiency is the main syndrome of lesion of the first segment of subclavian artery. About 20% of all ischemic strokes occur in vertebrobasilar basin. At present, surgical treatment of asymptomatic patients with severe lesion of the 1st segment of subclavian artery is still debatable. Open surgery is optimal for occlusion of this vascular segment. Carotid-subclavian transposition is a preferable option with favorable in-hospital and long-term results. However, carotid-subclavian bypass is an equivalent alternative in case of difficult transposition following anatomical and topographic features of vascular architectonics. Endovascular treatment is preferable for isolated subclavian artery stenosis and should certainly include stenting.
- 23 April 2023
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 12,p. 95-102
Treatment of atherosclerotic lesion of the first segment of subclavian artery
Severe subclavian artery lesion is an important medical and social problem worsening the quality of life and leading to dire consequences. Vertebrobasilar insufficiency is the main syndrome of lesion of the first segment of subclavian artery. About 20% of all ischemic strokes occur in vertebrobasilar basin. At present, surgical treatment of asymptomatic patients with severe lesion of the 1st segment of subclavian artery is still debatable. Open surgery is optimal for occlusion of this vascular segment. Carotid-subclavian transposition is a preferable option with favorable in-hospital and long-term results. However, carotid-subclavian bypass is an equivalent alternative in case of difficult transposition following anatomical and topographic features of vascular architectonics. Endovascular treatment is preferable for isolated subclavian artery stenosis and should certainly include stenting.